- Therapeutic use
- Antiepileptic
| Availability | API |
| Molecular Formula | C9H7Cl2N5 |
| IUPAC Nomenclature | 6-(2,3-Dichlorophenyl)-1,2,4-triazine-3,5-diyldiamine |
| Therapeutic Category | Antiepileptic for partial seizures and secondarily generalised tonic-clonic seizures |
| CAS Number | 84057-84-1 |
| Presentation | Europe: 25/50/100 mg tablets; 5/25/100 mg dispersible tabs US: 25/100/150/200 mg tablets |
